|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 33, 3378-3384, Copyright © 1992 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
R Parys-Van Ginderdeuren, D Malcolm, DR Varma, JV Aranda and S Chemtob
Department of Ophthalmology, University of Iowa, Iowa City.
To assess whether prostaglandins contribute to the control of basal retinal and choroidal hemodynamics, retinal (RBF) and choroidal blood flow (ChBF) were measured by a microsphere technique in 1- to 4-day-old pigs before and after (at 20 and 60 min) administration of indomethacin (0.3 mg/kg, n = 6 or 10 mg/kg, n = 5), ibuprofen (40 mg/kg, n = 7), naproxen (20 mg/kg, n = 5) or vehicle (n = 8). In 40 other animals, PGF2 alpha, PGE2, and 6-keto-PGF1 alpha were measured in the retina and choroid at times corresponding to blood flow measurements. Mean arterial blood pressure and blood gases and pH were not altered by any of the agents. Except for the lower dose of indomethacin (0.3 mg/kg), which did not change retinal and choroidal prostaglandin concentrations, the prostaglandin levels were decreased similarly (P < 0.01) by the three drugs. However, RBF and ChBF were not changed by ibuprofen and naproxen, but decreased to the same extent after low and high doses of indomethacin. The data suggest that the effects of indomethacin on RBF and ChBF cannot be simply attributed to prostaglandin synthesis inhibition, and that prostaglandins may not play a significant role in controlling basal blood flow to the retina and choroid.
This article has been cited by other articles:
![]() |
G. Weigert, F. Berisha, H. Resch, K. Karl, L. Schmetterer, and G. Garhofer Effect of Unspecific Inhibition of Cyclooxygenase by Indomethacin on Retinal and Choroidal Blood Flow Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1065 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
M H. Noergaard, D B. Pedersen, K Bang, P K. Jensen, J F. Kiilgaard, E Stefansson, and M la Cour Indomethacin decreases optic nerve oxygen tension by a mechanism other than cyclo-oxygenase inhibition Br J Ophthalmol, January 1, 2008; 92(1): 126 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Checchin, X. Hou, P. Hardy, D. Abran, T. Najarian, M. H. Beauchamp, S. G. Bernier, F. Gobeil Jr, C. Quiniou, D. R. Varma, et al. PGE2-Mediated eNOS Induction in Prolonged Hypercapnia Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1558 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Beauchamp, A. K. Martinez-Bermudez, F. Gobeil Jr., A. M. Marrache, X. Hou, G. Speranza, D. Abran, C. Quiniou, P. Lachapelle, J. Roberts II, et al. Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy J Appl Physiol, June 1, 2001; 90(6): 2279 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hardy, I. Dumont, M. Bhattacharya, X. Hou, P. Lachapelle, D. R. Varma, and S. Chemtob Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy Cardiovasc Res, August 18, 2000; 47(3): 489 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Najarian, P. Hardy, X. Hou, J. Lachapelle, A. Doke, F. Gobeil Jr., M.-S. Roy, P. Lachapelle, D. R. Varma, and S. Chemtob Preservation of neural function in the perinate by high PGE2 levels acting via EP2 receptors J Appl Physiol, August 1, 2000; 89(2): 777 - 784. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |